Literature DB >> 6542048

Effect of no treatment, cimetidine 1 g/day, cimetidine 2 g/day and cimetidine combined with atropine on nocturnal gastric secretion in cimetidine non-responders.

T Gledhill, M Buck, R H Hunt.   

Abstract

We have studied nocturnal acid secretion in patients with duodenal ulcer who met predetermined criteria of poor clinical response to cimetidine. Different groups of patients were investigated receiving either no treatment, cimetidine 1 g/day, cimetidine 2 g/day or cimetidine 1 g/day combined with atropine 4.8 mg/day. The results were compared with those obtained from other patients with duodenal ulcer who were studied in our department but who were not classified as according to their clinical response to cimetidine. The results show that despite adequate absorption, cimetidine has a decreased effect at controlling acid secretion in the poor responders and that increasing the dose of drug does not improve response. Control of acid output was, however, dramatically improved when cimetidine was combined with atropine which suggests that patients who do not respond to H2-receptor blockade should be treated by a combination of cimetidine with an anticholinergic agent.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6542048      PMCID: PMC1432313          DOI: 10.1136/gut.25.11.1211

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  15 in total

1.  High-pressure liquid chromatographic analysis of cimetidine, a histamine H2-receptor antagonist, in blood and urine.

Authors:  W C Randolph; V L Osborne; S S Walkenstein; A P Intoccia
Journal:  J Pharm Sci       Date:  1977-08       Impact factor: 3.534

2.  Effect of low-dose propantheline on food-stimulated gastric acid secretion: comparison with an "optimal effective dose" and interaction with cimetidine.

Authors:  M Feldman; C T Richardson; W L Peterson; J H Walsh; J S Fordtran
Journal:  N Engl J Med       Date:  1977-12-29       Impact factor: 91.245

3.  Effect of cimetidine on 24-hour intragastric acidity in normal subjects.

Authors:  R E Pounder; J G Williams; G J Milton-Thompson; J J Misiewicz
Journal:  Gut       Date:  1976-02       Impact factor: 23.059

4.  Intermittent treatment of duodenal ulcer with cimetidine.

Authors:  K D Bardhan
Journal:  Br Med J       Date:  1980-07-05

5.  Duodenal ulcer with unexplained marked basal gastric acid hypersecretion.

Authors:  P M Kirkpatrick; B I Hirschowitz
Journal:  Gastroenterology       Date:  1980-07       Impact factor: 22.682

6.  Reduction of twenty-four-hour gastric acidity with combination drug therapy in patients with duodenal ulcer.

Authors:  W L Peterson; C Barnett; M Feldman; C T Richardson
Journal:  Gastroenterology       Date:  1979-11       Impact factor: 22.682

7.  24-hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer during oral administration of cimetidine and atropine.

Authors:  R E Pounder; R H Hunt; S H Vincent; G J Milton-Thompson; J J Misiewicz
Journal:  Gut       Date:  1977-02       Impact factor: 23.059

8.  Cimetidine treatment of duodenal ulceration: short term clinical trial and maintenance study.

Authors:  D J Hetzel; P J Hansky; D J Shearman; M G Korman; R Hecker; G J Taggart; R Jackson; B W Gabb
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

9.  Very long-term treatment of peptic ulcer with cimetidine.

Authors:  J M Cargill; J H Saunders; N Peden; K G Wormsley
Journal:  Lancet       Date:  1978-11-25       Impact factor: 79.321

10.  Cimetidine in duodenal ulcer. Controlled trial.

Authors:  W S Blackwood; D P Maudgal; R G Pickard; D Lawrence; T C Northfield
Journal:  Lancet       Date:  1976-07-24       Impact factor: 79.321

View more
  19 in total

1.  pH-feedback controlled infusions of ranitidine are no more effective than fixed-dose infusions in reducing gastric acidity and variability in antisecretory responses.

Authors:  C H Wilder-Smith; F Halter; W Häcki; H S Merki
Journal:  Br J Clin Pharmacol       Date:  1992-05       Impact factor: 4.335

2.  Frequent non-response to histamine H2-receptor antagonists in cirrhotics.

Authors:  S Walker; D R Krishna; U Klotz; J C Bode
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

3.  Refractory duodenal ulcers (nonhealing duodenal ulcers with standard doses of antisecretory medication).

Authors:  M J Collen; V J Stanczak; C A Ciarleglio
Journal:  Dig Dis Sci       Date:  1989-02       Impact factor: 3.199

4.  Gastric acid secretion stimulated by modified sham-feeding, and the effects of histamine H2-antagonist and anti-muscarinic agent in patients with duodenal ulcer.

Authors:  S Ooi; E Kaneko
Journal:  Gastroenterol Jpn       Date:  1989-10

Review 5.  Gastroenterology in the armed forces.

Authors:  G Milton-Thompson
Journal:  Gut       Date:  1989-11       Impact factor: 23.059

6.  Effect of cimetidine and pirenzepine in combination on 24 hour intragastric acidity in subjects with previous duodenal ulceration.

Authors:  J G Williams; M Deakin; J K Ramage
Journal:  Gut       Date:  1986-04       Impact factor: 23.059

7.  The refractory ulcer.

Authors:  D W Piper
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

8.  Twenty four hour intragastric acidity analysis for the future.

Authors:  R Walt
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

9.  Large single daily dose of histamine H2 receptor antagonist for duodenal ulcer. How much and when? A clinical pharmacological study.

Authors:  M Deakin; H P Glenny; J K Ramage; J G Mills; W L Burland; J G Williams
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

10.  Bleeding duodenal ulcer. Role of gastric acid hypersecretion.

Authors:  M J Collen; A N Kalloo; M J Sheridan
Journal:  Dig Dis Sci       Date:  1993-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.